Study identifies biomarker for the onset & progression of MS

A board to discuss Low Dose Naltrexone (LDN) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: 9 years ago
Contact:

Study identifies biomarker for the onset & progression of MS

Post by MSUK » 1 year ago

A team of researchers have identified Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS)...Read more - http://www.ms-uk.org/study-identifies-b ... ression-ms

Image
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post